| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.100 | None | 1.000 | 2 | 7 | 2016 | 2019 | ||||||||
|
RAB5B, member RAS oncogene family | 0.722 | 0.346 | 2.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAD51 paralog B | 0.556 | 0.769 | 2.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
TNF receptor superfamily member 10c | 0.578 | 0.731 | 3.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
interleukin 1 receptor associated kinase 2 | 0.722 | 0.385 | 2.6E-19 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
inositol polyphosphate-5-phosphatase D | 0.558 | 0.731 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
interleukin 5 receptor subunit alpha | 0.647 | 0.654 | 2.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2019 | ||||||||
|
sphingosine-1-phosphate receptor 4 | 0.722 | 0.346 | 2.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
interleukin 4 receptor | 0.474 | 0.846 | 2.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
glucocorticoid induced 1 | 0.716 | 0.385 | 5.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2016 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
CD200 receptor 1 | 0.623 | 0.769 | 4.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RNA binding protein, mRNA processing factor | 0.780 | 0.423 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
EH domain containing 4 | 0.931 | 0.115 | 4.2E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2019 | ||||||||
|
lysophosphatidic acid receptor 1 | 0.534 | 0.808 | 0.19 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2019 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
signal transducer and activator of transcription 6 | 0.475 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
sprouty related EVH1 domain containing 2 | 0.711 | 0.577 | 2.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
endosulfine alpha | 0.760 | 0.308 | 0.35 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1619 | 0.931 | 0.192 | 8.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
bromodomain PHD finger transcription factor | 0.560 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 |